- Amidst increasing awareness regarding potential health benefits of cannabinoids, Lexaria is at the forefront of a booming industry
- LXRP stakeholders have the opportunity to participate on a global scale to improve the delivery and performance of various products
- Lexaria’s patented technology provides an enabling layer in cannabinoid research and development, existing products and applications
Amidst increasing awareness regarding cannabinoids and their potential health benefits, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is at the forefront of the booming cannabis industry with its patented delivery technology, DehydraTECH. The technology provides an enabling layer to advances in cannabinoid research and development as well as existing products and applications, and allows LXRP and stakeholders to participate, on a global scale, in the medical marijuana market that is expected to reach a value of USD $55.8 billion by 2025 according to a report by Grand View Research, Inc. (http://cnw.fm/E2yT5)
John Docherty, President of Lexaria Bioscience Corp., recently issued a video clip discussing the company’s innovative technology that allows for the enhanced flavor and faster absorption of edible products. He discussed opportunities LXRP stakeholders have in commercial applications via third-party licensing in order to leverage…
More from CannabisNewsWire
- Success of Initial Coin Offerings (ICOs) Shows Increasing Application of Blockchain Technology to Payment Solutions
- Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Providing Clinical Proof of Cannabis Efficiency
- Bitcoin’s Rise Solidifies the Intersection of Cannabis and Cryptocurrency
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net